Literature DB >> 15213854

Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases.

Tomohiro Sase1, Hideo Wada, Yuko Kamikura, Toshihiro Kaneko, Yasunori Abe, Junji Nishioka, Tsutomu Nobori, Hiroshi Shiku.   

Abstract

We compared the levels of tissue factor (TF) mRNA in leukocytes with plasma TF antigens of patients in hypercoagulable state caused by various diseases. Flow cytometric analysis showed absence of TF antigen expression on neutrophils and monocytes in healthy subjects but strong expression in both cell types of patients with infections.TF mRNA levels in leukocytes were low in healthy subjects but they were significantly elevated in patients with underlying diseases of disseminated intravascular coagulation (DIC), especially in acute myeloid leukaemia (AML) and infections.TF mRNA levels in leukocytes were significantly high in patients with all diseases except those with thrombosis, and plasma TF antigen levels were significantly high in all diseases. TF mRNA in leukocytes and plasma TF antigen levels were significantly high in patients with overt-DIC, and TF mRNA/antigen ratio was significantly high in patients with overt-DIC. In patients with solid cancers, TF mRNA and TF mRNA/antigen ratio were significantly higher in patients with metastases than those without. TF mRNA levels in leukocytes and plasma levels of TF antigen did not correlate in normal subjects and all patients, but they tended to be correlated in patients with AML, infections or overt-DIC. Our analysis suggests that TF expression in leukocytes plays an important role in various diseases but the expression level does not always correlate with plasma levels of TF antigen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213854     DOI: 10.1160/TH03-08-0535

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation.

Authors:  Stephan L Haas; Ralf Jesnowski; Michael Steiner; Frank Hummel; Jörg Ringel; Christine Burstein; Horst Nizze; Stefan Liebe; J Matthias Löhr
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

2.  The association of timing of pharmacological prophylaxis and venous thromboembolism in patients with moderate-to-severe traumatic brain injury: A retrospective cohort study.

Authors:  Hasan M Al-Dorzi; Ghadah Al-Yami; Fatima Al-Daker; Muhannad Q Alqirnas; Moustafa S Alhamadh; Raymond Khan
Journal:  Ann Thorac Med       Date:  2022-04-19       Impact factor: 2.535

3.  Deep vein thrombosis prophylaxis in trauma patients.

Authors:  Serdar Toker; David J Hak; Steven J Morgan
Journal:  Thrombosis       Date:  2011-05-15

4.  Incidence and risk factors of preoperative deep vein thrombosis in patients with intertrochanteric fractures: a retrospective study.

Authors:  Kai Song; Bowen Zhu; Yao Yao; Qing Jiang; Jin Xiong; Hongfei Shi
Journal:  J Orthop Surg Res       Date:  2022-08-03       Impact factor: 2.677

Review 5.  Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.

Authors:  Hideo Wada; Takeshi Matsumoto; Kei Suzuki; Hiroshi Imai; Naoyuki Katayama; Toshiaki Iba; Masanori Matsumoto
Journal:  Thromb J       Date:  2018-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.